Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 149.30M
March 31, 2026 -0.50M
December 31, 2025 84.50M
September 30, 2025 64.30M
June 30, 2025 174.30M
March 31, 2025 174.80M
December 31, 2024 -0.60M
September 30, 2024 -0.60M
June 30, 2024 -0.70M
March 31, 2024 249.40M
December 31, 2023 -0.60M
September 30, 2023 -0.80M
June 30, 2023 -0.80M
March 31, 2023 249.10M
December 31, 2022 -0.80M
September 30, 2022 -1.80M
June 30, 2022 -0.70M
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 -7.80M
March 31, 2021 7.80M
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 -0.60M
December 31, 2019 -0.10M
September 30, 2019 -4.00M
June 30, 2019 -1.60M
March 31, 2019 -2.40M
December 31, 2018 -2.20M
September 30, 2018 -1.90M
June 30, 2018 -2.90M
March 31, 2018 421.20M
December 31, 2017 495.20M
September 30, 2017 -3.90M
June 30, 2017 -3.90M
March 31, 2017 -5.00M
December 31, 2016 -2.70M
September 30, 2016 -4.30M
June 30, 2016 -3.20M
March 31, 2016 -3.60M
December 31, 2015 62.60M
September 30, 2015 -6.40M
June 30, 2015 -19.00M
March 31, 2015 -67.40M
December 31, 2014 -19.60M
September 30, 2014 -4.30M
June 30, 2014 -8.00M
March 31, 2014 -21.90M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Pfizer Inc. 0.00
Eli Lilly & Co. 1.601B
Merck & Co., Inc. 714.00M
Bristol Myers Squibb Co. 0.00
Johnson & Johnson -138.00M